A model for network-based identification and pharmacological targeting of aberrant, replication-permissive transcriptional programs induced by viral infection
Master Regulator proteins, controlling the transcriptional identity of infected cells, can serve as drug targets for inhibiting virus replication, here demonstrated in a SARSCoV-2 infection model.
Main Authors: | Pasquale Laise, Megan L. Stanifer, Gideon Bosker, Xiaoyun Sun, Sergio Triana, Patricio Doldan, Federico La Manna, Marta De Menna, Ronald B. Realubit, Sergey Pampou, Charles Karan, Theodore Alexandrov, Marianna Kruithof-de Julio, Andrea Califano, Steeve Boulant, Mariano J. Alvarez |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2022-07-01
|
Series: | Communications Biology |
Online Access: | https://doi.org/10.1038/s42003-022-03663-8 |
Similar Items
-
Importance of Type I and III Interferons at Respiratory and Intestinal Barrier Surfaces
by: Megan L. Stanifer, et al.
Published: (2020-12-01) -
Dynamics of Virus-Receptor Interactions in Virus Binding, Signaling, and Endocytosis
by: Steeve Boulant, et al.
Published: (2015-06-01) -
Single‐cell analyses reveal SARS‐CoV‐2 interference with intrinsic immune response in the human gut
by: Sergio Triana, et al.
Published: (2021-04-01) -
Systematic, network-based characterization of therapeutic target inhibitors.
by: Yao Shen, et al.
Published: (2017-10-01) -
Regionalization of the antiviral response in the gastrointestinal tract to provide spatially controlled host/pathogen interactions
by: Megan L. Stanifer, et al.
Published: (2023-08-01)